Anebulo Pharmaceuticals, Inc. Common Stock (ANEB) Income Statement (2020 - 2025)
Income Statement report data from Sep 30, 2020 to Dec 31, 2025 for Anebulo Pharmaceuticals, Inc. Common Stock (ANEB).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||
Total Revenue | - | - | - | - | - | - | -140.00K | 70K (-12.50%) | 80K | - | -90.00K | 80K (+700.00%) | 10K | - | - | - | - | - | - | - | - | - |
Operating Expenses | ||||||||||||||||||||||
Research And Development | 1.16M (+43.21%) | 810K (-28.32%) | 1.13M (+76.56%) | 640K (-47.54%) | 1.22M (-6.87%) | 1.31M (+178.72%) | 470K (-37.33%) | 750K (-29.25%) | 1.06M (-16.54%) | 1.27M (-10.56%) | 1.42M (+30.28%) | 1.09M (-41.71%) | 1.87M (+53.28%) | 1.22M (+8.93%) | 1.12M (+21.74%) | 920K (+338.10%) | 210K (-70.83%) | 720K (-60.22%) | 1.81M (+570.37%) | 270K (+58.82%) | 170K (+750.00%) | 20K |
Selling General And Administrative | 1.46M (+0.69%) | 1.45M (+20.83%) | 1.20M (-4.00%) | 1.25M (-8.76%) | 1.37M (+24.55%) | 1.10M (+26.44%) | 870K (-5.43%) | 920K (-45.88%) | 1.70M (+33.86%) | 1.27M (+17.59%) | 1.08M (-38.98%) | 1.77M (-8.76%) | 1.94M (+39.57%) | 1.39M (+14.88%) | 1.21M (+26.04%) | 960K (+11.63%) | 860K (+2.38%) | 840K (+23.53%) | 680K (+142.86%) | 280K (+86.67%) | 150K (-34.78%) | 230K |
Operating Expenses | 2.62M (+15.93%) | 2.26M (-3.00%) | 2.33M (+23.28%) | 1.89M (-27.03%) | 2.59M (+7.47%) | 2.41M (+79.85%) | 1.34M (-19.28%) | 1.66M (-39.86%) | 2.76M (+8.66%) | 2.54M (+2.01%) | 2.49M (-12.94%) | 2.86M (-24.93%) | 3.81M (+45.98%) | 2.61M (+12.02%) | 2.33M (+23.94%) | 1.88M (+75.70%) | 1.07M (-30.97%) | 1.55M (-37.50%) | 2.48M (+350.91%) | 550K (+71.88%) | 320K (+28.00%) | 250K |
Operating Income | ||||||||||||||||||||||
Operating Income | -2.62M (+15.93%) | -2.26M (-3.00%) | -2.33M (+23.28%) | -1.89M (-27.03%) | -2.59M (+7.47%) | -2.41M (+79.85%) | -1.34M (-19.28%) | -1.66M (-39.86%) | -2.76M (+8.66%) | -2.54M (+2.01%) | -2.49M (-12.94%) | -2.86M (-24.93%) | -3.81M (+45.98%) | -2.61M (+12.02%) | -2.33M (+23.94%) | -1.88M (+75.70%) | -1.07M (-30.97%) | -1.55M (-43.43%) | -2.74M (+398.18%) | -550.00K (+71.88%) | -320.00K | - |
Ebit | -2.62M (+15.93%) | -2.26M (-3.00%) | -2.33M (+23.28%) | -1.89M (-27.03%) | -2.59M (+7.47%) | -2.41M (+79.85%) | -1.34M (-19.28%) | -1.66M (-39.86%) | -2.76M (+8.66%) | -2.54M (+2.01%) | -2.49M (-12.94%) | -2.86M (-24.93%) | -3.81M (+45.98%) | -2.61M (+12.02%) | -2.33M (+23.94%) | -1.88M (+75.70%) | -1.07M (-30.97%) | -1.55M (-37.50%) | -2.48M (+350.91%) | -550.00K (+71.88%) | -320.00K (+23.08%) | -260.00K |
EBITDA | -1.98M (-7.48%) | -2.14M (+4.90%) | -2.04M (+29.11%) | -1.58M (-33.05%) | -2.36M (+12.38%) | -2.10M (+69.35%) | -1.24M (-22.01%) | -1.59M (-40.89%) | -2.69M (+8.47%) | -2.48M (-0.80%) | -2.50M (-10.71%) | -2.80M (-26.89%) | -3.83M (+46.74%) | -2.61M (+12.50%) | -2.32M (+23.40%) | -1.88M (+75.70%) | -1.07M (-30.97%) | -1.55M (-94.67%) | -29.10M (+5190.91%) | -550.00K (+66.67%) | -330.00K (+26.92%) | -260.00K |
Other Income / Expenses | ||||||||||||||||||||||
Interest Expense | 20K (0.00%) | 20K (-80.00%) | 100K (0.00%) | 100K (0.00%) | 100K (0.00%) | 100K (-9.09%) | 110K (+83.33%) | 60K (+100.00%) | 30K | - | - | - | - | - | - | - | - | - | 10K | - | - | - |
Net Interest Income | -20.00K (0.00%) | -20.00K (-80.00%) | -100.00K (0.00%) | -100.00K (0.00%) | -100.00K (0.00%) | -100.00K (-9.09%) | -110.00K (+83.33%) | -60.00K (+100.00%) | -30.00K | - | - | - | - | - | - | - | - | - | -10.00K | - | - | - |
Other Non Operating Income | - | - | - | - | - | - | 10K | - | - | 10K | -40.00K (+300.00%) | -10.00K (-50.00%) | -20.00K | - | - | - | - | - | - | - | - | - |
Net Income | ||||||||||||||||||||||
Income Before Tax | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.55M | - | - | -1.55M (-44.84%) | -2.81M (+401.79%) | -560.00K | - | -250.00K |
Net Income From Continuing Operations | -2.00M (-7.41%) | -2.16M (+0.93%) | -2.14M (+27.38%) | -1.68M (-31.71%) | -2.46M (+11.82%) | -2.20M (+62.96%) | -1.35M (-18.18%) | -1.65M (-39.34%) | -2.72M (+9.68%) | -2.48M (-0.80%) | -2.50M (-10.71%) | -2.80M (-26.89%) | -3.83M (+46.74%) | -2.61M (+12.50%) | -2.32M (+23.40%) | -1.88M (+75.70%) | -1.07M (-30.97%) | -1.55M (-94.68%) | -29.11M (+5098.21%) | -560.00K (+69.70%) | -330.00K (+26.92%) | -260.00K |
Net Income | -2.00M (-7.41%) | -2.16M (+0.93%) | -2.14M (+27.38%) | -1.68M (-31.71%) | -2.46M (+11.82%) | -2.20M (+62.96%) | -1.35M (-18.18%) | -1.65M (-39.34%) | -2.72M (+9.68%) | -2.48M (-0.80%) | -2.50M (-10.71%) | -2.80M (-26.89%) | -3.83M (+46.74%) | -2.61M (+12.50%) | -2.32M (+23.40%) | -1.88M (+75.70%) | -1.07M (-30.97%) | -1.55M (-94.68%) | -29.11M (+5098.21%) | -560.00K (+69.70%) | -330.00K (+26.92%) | -260.00K |